RNA modification

pathway activity — cross-omics
GO:0009451Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the RNA modification pathway is significantly associated with the RNA expression of multiple genes, with the OV cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CXCL12, CDH23, and SIGLEC9, each associated with the pathway in up to 3 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, RNA modification activity versus CXCL12 in OV (Pearson r = -0.41).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
OVCXCL12 →-1.568-0.195<.001<.00133
COADCDH23 →-0.126-0.147.006.00733
OVSIGLEC9 →-0.693-0.207.001<.00133
OVEIF5A2 →-0.853-0.134<.001.00833
COADPTAFR →-0.539-0.155.002<.00133
COADRASGRP4 →-0.567-0.259<.001<.00133
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0009451 vs CXCL12 — OV

Per-sample scatter of RNA modification activity vs CXCL12 in OV.

Explore this scatter interactively →

Exploration